Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Platform
1.2. Estimates and forecast timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Service type outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Landscape Snapshot
Chapter 3. mHealth Apps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High penetration of smartphones
3.2.1.2. Favorable government initiatives
3.2.1.3. Growing adoption of mobile health applications
3.2.1.4. Increase in investments supporting mHealth & digital health
3.2.2. Market restraint analysis
3.2.2.1. Concerns related to data security
3.3. Case Study Analysis
3.3.1. Case Study 1: Kilkari: a mobile health service for mothers in India
3.3.2. Case Study 2: Momconnect: empowering mothers in south africa
3.3.3. Case Study 3: Integrating mobile technology with existing healthcare infrastructure to enhance healthcare accessibility
3.3.4. Case Study 4: Jhpiego’s mwater project
3.3.5. Case Study 5: A web platform for clinician & patient interaction
3.3.6. Case Study 6: European firms have created digital technologies that can scale up to offer solutions for clinical settings, remote care, health insurance, and patient-centered eHealth services
3.3.7. Case Study 7: SMS to promote medicines adherence in South Africa
3.3.8. Case Study 8: MPOWER: Improving HIV medication adherence in Rwanda
3.3.9. Case Study 9: Omada Health: Digital tools for weight loss and diabetes prevention
3.4. Business Environment Analysis
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
Chapter 4. mHealth Apps Market Segment Analysis, By Type, 2018 – 2030 (USD Million)
4.1. Definitions and Scope
4.2. Type Segment Dashboard
4.3. Global mHealth Apps Market, by Service Type, 2018 to 2030
4.4. Medical Apps
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Women’s Health Apps
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.2. Fitness & Nutrition Apps
4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.3. Menstrual Health
4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.4. Pregnancy Tracking & Postpartum Care Apps
4.4.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.5. Disease Management Apps
4.4.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.6. Menopause Apps
4.4.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.7. Others
4.4.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Chronic Disease Management Apps
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.2. Obesity Management Apps
4.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.3. Mental Health Management Apps
4.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.4. Diabetes Management Apps
4.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.5. Blood Pressure and ECG Monitoring Apps
4.4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.6. Cancer Management Apps
4.4.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.7. Other Chronic Disease Management Apps
4.4.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Personal Health Record Apps
4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.5. Medication Management Apps
4.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.6. Diagnostic Apps
4.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.7. Remote Monitoring Apps
4.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.8. Others (Pill Reminder, Medical Reference, Professional Networking, Healthcare Education)
4.4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Fitness Apps
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. mHealth Apps Market Segment Analysis, By Platform, 2018 – 2030 (USD Million)
5.1. Definitions and Scope
5.2. Platform Segment Dashboard
5.3. Global mHealth Apps Market by Platform Outlook, 2018 to 2030
5.4. Android
5.4.1. Market estimates and forecast 2018 to 2030 (USD million)
5.5. iOS
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. mHealth Apps Market: Segment Analysis, by Region, by Type, by Platform, 2018 – 2030 (USD Million)
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. SWOT Analysis
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company market share analysis, 2023
7.4. Company Profiles
7.4.1. Apple Inc.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Google Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. AirStrip Technologies, Inc.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Samsung Electronics Co. Ltd.
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Veradigm LLC (Allscripts Healthcare Solutions)
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Qualcomm Technologies, Inc.
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. AT&T
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Orange
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Teladoc Health, Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. AstraZeneca
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Abbott
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Sanofi
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Johnson & Johnson Services, Inc.
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. Novartis AG
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
7.4.15. Pfizer Inc.
7.4.15.1. Company overview
7.4.15.2. Financial performance
7.4.15.3. Product benchmarking
7.4.15.4. Strategic initiatives
|